Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GSID was founded by experienced vaccine developers and has focused on developing vaccines and diagnostic tools for major infectious diseases affecting the developing world, especially HIV. The organization’s founders previously led the world’s first Phase III clinical trials of an HIV vaccine at VaxGen. Current clinical results or active trial data are not detailed in public sources, but GSID continues to support product development and global health initiatives related to diagnostics and prevention[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Solutions for Infectious Diseases.